Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for teens with type 2 diabetes: Higher-Dose dulaglutide under study

NCT ID NCT06739122

Disease control Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 4 times

Summary

This study tests two higher doses (3.0 mg and 4.5 mg) of the diabetes drug dulaglutide in teenagers aged 10 to 17 with type 2 diabetes. The goal is to see if these doses are safe and help control blood sugar and weight. Participants will receive weekly injections for about 8 months, and the study is currently recruiting 55 teens.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dulaglutide (a once-weekly injection that helps lower blood sugar)
What this could lead to
If successful, this could provide higher-dose options for teenagers with type 2 diabetes to better manage their blood sugar and weight.
What could go wrong
This is a single-arm, open-label study with no placebo group, so results may be less reliable. Side effects like nausea or stomach issues are possible, and the trial is small (55 participants).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 55 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Have Type 2 diabetes treated with diet and exercise and metformin and/or basal insulin. Metformin and/or basal insulin dose must be stable for at least 8 weeks prior to screening. * Have a body weight ≥50 kilograms (kg) and Body Mass Index (BMI) of \>85th percentile Exclusion Criteria: * Have Type 1 diabetes * Have received treatment with any glucose-lowering agent(s) other than metformin, basal insulin, or dulaglutide within 8 weeks prior to screening * After the Type 2 diabetes diagnosis, have a history of diabetic ketoacidosis or hyperosmolar syndrome * Have had ≥1 episode of severe hypoglycemia and/or ≥1 episode of hypoglycemic unawareness within the last 6 months * Have family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) * Have prior chronic, recurrent, or idiopathic pancreatitis, or known gallbladder disease * Have been treated with prescription drugs or over-the-counter medications that promote weight loss within 8 weeks prior to screening

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    51 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AdventHealth Orlando

    RECRUITING

    Orlando, Florida, 32803, United States

  • Arkansas Childrens Hospital

    RECRUITING

    Little Rock, Arkansas, 72202-3500, United States

  • Arké SMO S.A de C.V

    NOT_YET_RECRUITING

    Veracruz, 91910, Mexico

  • Center for Diabetes and Metabolic Diseases Indiana University

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Centricity Research Columbus Endocrinology

    RECRUITING

    Columbus, Georgia, 31904, United States

  • Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada

    RECRUITING

    Buenos Aires, C1425, Argentina

  • Centro de Estudios de Investigacion Metabolicos y Cardiovasculares

    NOT_YET_RECRUITING

    Ciudad Madero, 89440, Mexico

  • Centro de Investigaciones Médicas Mar del Plata

    NOT_YET_RECRUITING

    Mar del Plata, B7600FYK, Argentina

  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics

    RECRUITING

    Atlanta, Georgia, 30329, United States

  • Children's Hospital of Colorado

    NOT_YET_RECRUITING

    Denver, Colorado, 80045, United States

  • Children's Hospital of Philadelphia

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Children's National Medical Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Children's Wisconsin - Milwaukee Campus

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Childrens Hospital Medical Center

    RECRUITING

    Cincinnati, Ohio, 45229, United States

  • Cleveland Clinic Childrens Outpatient Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • Clínica Cemain

    NOT_YET_RECRUITING

    Tampico, 89210, Mexico

  • Clínica Mayo de Urgencias Médicas Cruz Blanca S.R.L

    RECRUITING

    San Miguel de Tucumán, T4000IHE, Argentina

  • Cohen Children's Medical Center Division of Pediatric Endocrinology

    RECRUITING

    Hyde Park, New York, 11042, United States

  • D&H National Research Centers, Inc

    RECRUITING

    Miami, Florida, 33155, United States

  • D&H Tamarac Research Center, LLC

    RECRUITING

    Tamarac, Florida, 33321, United States

  • Division of Endocrinology, Diabetes, and Metabolism

    RECRUITING

    Los Angeles, California, 90027, United States

  • Emerson Clinical Research Institute

    RECRUITING

    Washington D.C., District of Columbia, 20009, United States

  • Go Centro Medico San Nicolás

    RECRUITING

    San Nicolás, 2900, Argentina

  • Hospital Angeles (HA) - Puebla

    NOT_YET_RECRUITING

    Puebla City, 72190, Mexico

  • INECO Neurociencias Oroño

    RECRUITING

    Rosario, 2000, Argentina

  • Innovacion y Desarrollo de Estrategias en Salud SA de CV

    NOT_YET_RECRUITING

    Tlalpan, 14090, Mexico

  • Johns Hopkins University School of Medicine

    RECRUITING

    Baltimore, Maryland, 21287, United States

  • Nemours Children's Health

    RECRUITING

    Jacksonville, Florida, 32207, United States

  • Norton Children's Endocrinology

    RECRUITING

    Louisville, Kentucky, 40202, United States

  • Prisma Health Midlands

    RECRUITING

    Greenville, South Carolina, 29615, United States

  • Prisma Health Pediatric Endocrinology

    RECRUITING

    Columbia, South Carolina, 29203, United States

  • Research Institute of Dallas

    RECRUITING

    Dallas, Texas, 75231, United States

  • SUNY Upstate Medical University

    RECRUITING

    Syracuse, New York, 13210, United States

  • Seattle Children's Hospital

    RECRUITING

    Seattle, Washington, 98105, United States

  • St Christophers Hospital For Children

    RECRUITING

    Philadelphia, Pennsylvania, 19134, United States

  • St. Luke's Children's Endocrinology and Diabetes

    RECRUITING

    Boise, Idaho, 83712, United States

  • Texas Childrens Hospital

    RECRUITING

    Houston, Texas, 77030, United States

  • UCLA Mattel Children's Hospital

    RECRUITING

    Los Angeles, California, 90095, United States

  • UNC Children's Hospital

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

  • UT Health Houston

    RECRUITING

    Houston, Texas, 77030, United States

  • University of Arizona

    RECRUITING

    Tucson, Arizona, 85724, United States

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94158, United States

  • University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 60612, United States

  • University of Iowa Stead Family Children's Hospitals

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, 39216, United States

  • University of New Mexico Hospital

    RECRUITING

    Albuquerque, New Mexico, 87106, United States

  • University of Oklahoma Health Sciences Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • University of South Florida

    RECRUITING

    Tampa, Florida, 33612, United States

  • University of Utah

    RECRUITING

    Salt Lake City, Utah, 84112, United States

  • WBMD Pediatrics

    RECRUITING

    Buffalo, New York, 14203, United States

  • Yale Diabetes Research

    RECRUITING

    New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.